News GenoScreen Corporate
GenoScreen becomes a Certified Service Provider by Oxford Nanopore Technologies
GenoScreen is now a certified service provider of Oxford Nanopore Technologies.
Meet us at the 42nd Annual Congress of the European Society of Mycobacteriology (ESM) from June 26th to 29th in Bologna, Italy.
The program of this 42nd edition has for main topics Covid and Tuberculosis and will address new diagnostic strategies.
GenoScreen and Illumina Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
GenoScreen, world specialist in TB genomic solutions, and Illumina partner to expand access to a package combining Deeplex® Myc-TB assay and Illumina sequencing products.
Meet us at the 32th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Meet us at the 32th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) from April 23th to 26th in Lisbon, Portugal.
Meet us at the 18th International Symposium on Microbial Ecology (ISME), Lausanne – Switzerland
The new edition of the International Symposium on Microbial Ecology a staple meeting in the field, will cover many topics, in environment, human and animal health, and bioprocesses.
Meet GenoScreen at the Adebiotech High Throughput Sequencing Applications Webinar
Adebiotech is holding a new edition of its webinar dedicated to the applications of high throughput NGS sequencing on March 10th 2022.
Dr Philip Supply receives the Gardner Middlebrook Lifetime Achievement Award 2022
Dr Philip Supply, Director of Research at the CNRS and Scientific Adviser at GenoScreen, has received the prestigious Gardner Middlebrook Lifetime Achievement Award at the 42nd Annual Congress of the European Society of Mycobacteriology (ESM) on 26 June 2022 in Bologna – Italy.
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
GenoScreen and ScienceVision announce an agreement to commercialize the Deeplex® Myc-TB test in Malaysia, Myanmar and Brunei.